PHARMASEVEN OÜ
Date of report 13.01.2025
Open the reports you want to print
Employees and salaries
PHARMASEVEN OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
PHARMASEVEN OÜ
Former decision-makers?
Relations: 2
Turnover 2024: 1 943 €
Employees: 1
Ene Solovjev
★★★★
......
Credit Score: Trustworthy
Reputation score: 350
Date of birth: ......
Active relations 2
Relations: 1
Turnover 2024: 3 835 586 €
Employees: 8
Anastassia Izlatova
★★★★
......
Credit Score: Trustworthy
Reputation score: 2000
Date of birth: ......
Active relations 1
PHARMASEVEN OÜ
History of right of representation?
Field
Trading
Business age
3y
Beneficial country:
et
Anastassia Izlatova ... - ...
Ene Solovjev ... - ...
2020
2021
2022
2023
2024
2025
2020
2021
2022
2023
2024
2025
PHARMASEVEN OÜ
Owners?
Former owners
PHARMASEVEN OÜ
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... |
Finances and assets
PHARMASEVEN OÜ
Taxes paid and estimated average salariesPHARMASEVEN OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2023 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
PHARMASEVEN OÜ
Sales revenue by business areaPHARMASEVEN OÜ
Financial indicators and prognosisPHARMASEVEN OÜ
Financial raiting: "SATISFACTORY" (2023 prognosis)2023 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
PHARMASEVEN OÜ
Annual reportsLiabilities and debts
PHARMASEVEN OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
PHARMASEVEN OÜ
Reports and assets-liabilities overview 28.09.2023?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
PHARMASEVEN OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
PHARMASEVEN OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2023 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
PHARMASEVEN OÜ
Bailiff's enforcement proceedings as of 28.09.2023?
Bailiff's enforcement proceedings MISSING
PHARMASEVEN OÜ
Regulations of the Payment Order Department as of 28.09.2023?
Regulations of the Payment Order Department MISSING
PHARMASEVEN OÜ
Court orders in the register as of 28.09.2023?
Puuduste kõrvaldamise määrus
15.09.2023
Regulation number: Ä 50140288 / M1
Regulation status has entered into force: 15.09.2023
Regulation status: Allkirjastatud
PHARMASEVEN OÜ
Decisions of the Consumer Disputes Committee as of 28.09.2023?
Consumer disputes MISSING
PHARMASEVEN OÜ
Court hearings as of 28.09.2023?
Number of the case: 2-20-14136
Harju Maakohus Tallinna kohtumaja
03.05.2021
| Chamber: | kohtusaal nr 4003 |
| Judge: | Anu Uritam |
| Description of hearings: | ...... |
PHARMASEVEN OÜ
Rulings as of 28.09.2023?
Kohtumäärus tsiviilasjas nr 2-20-14255/19
Tallinna Ringkonnakohtu tsiviilkolleegium
26.02.2021
| Related companies: | |
| Number of the case: | 2-20-14255/19 |
| Type of procedure: | Tsiviilasi |
| Court: | Tallinna Ringkonnakohtu tsiviilkolleegium |
| Type of solution: | Kohtumäärus |
| Solution subcategory: | - |
| Composition of the Court: | Peeter Pällin, Margo Klaar, Ele Liiv |
| Commencement of the Court case: | 30.09.2020 |
| Type of procedure: | Määruskaebusmenetlus |
| Commencement of proceedings: | 10.12.2020 |
| Court case category: | Võlaõigus |
| Keyword: | - |
| Court decision date: | 26.02.2021 |
| Entry into force: | 19.03.2021 |
| Dissenting opinion: | |
| ECLI identifier: ? |
ECLI:EE:TLRK:2021:2.20.14255.3405 |
PHARMASEVEN OÜ
Notices and announcements as of 28.09.2023?
Notice of merger
29.09.2023
Marketing
Business network
PHARMASEVEN OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
PHARMASEVEN OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.